← Back to Search

Non-Invasive Brain Stimulation

Patients with BPD assigned to the trial of 10 active tDCS sessions followed by psychotherapy for Borderline Personality Disorder

N/A
Waitlist Available
Research Sponsored by Ciusss de L'Est de l'Île de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a treatment that uses gentle electrical or magnetic pulses to stimulate the brain. It aims to help people with Borderline Personality Disorder who struggle with impulsive behavior. Participants will also receive short-term psychotherapy for a few months.

Eligible Conditions
  • Borderline Personality Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The effect of NIBS on impulsivity (UPPS- Behavioral Impulsive scale)
Secondary study objectives
The Effect of tDCS on Risk taking ( an impulsive behavior dimension)
The effect of tDCS on BPD severity overall ( Borderline Personality Disorder Severity Index: BPDSI)
the effect of tDCS on depressive symptoms in BPD (Montgomery-Asberg Depression Rating Scale (MADRS))

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with BPD assigned to the trial of 10 active tDCS sessions followed by psychotherapyExperimental Treatment1 Intervention
Patients diagnosed with Borderline Personality disorder and BPDSI score is \> or = 17 will be assigned for active tDCS session (NeuroConn, Germany) candidates will have 20-minute session per day for 10 weekdays in 2 weeks. Then they will attend short term psychotherapy session for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NeuroConn
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Dr. Lionel Cailhol, chef of psychiatry department at Montreal Psychiatric Institute (IUSMM)UNKNOWN
Ciusss de L'Est de l'Île de MontréalLead Sponsor
78 Previous Clinical Trials
6,402 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
403 Patients Enrolled for Borderline Personality Disorder
Dr. Lionel Cailhol, checf of psychiatry department at Montreal Psychiatric Institute (IUSMM)UNKNOWN
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top